About Ytiliga
Ytiliga is a Healthcare company based in Delhi (India) founded in 2016. Ytiliga develops, manufactures, and distributes specialty pharmaceutical drugs internationally. It operates on a B2B model. The company has 14 employees. Its website ytiliga.com draws about 681 thousand monthly visits. Its Indian entity Ytiliga Private Limited reported revenue of ₹1.14 Cr. Ytiliga offers products and services including UroTron™, NephroTron™, AndroXprts™, and CNStron™. Its focus areas include Life Sciences, Biopharmaceuticals, Innovation and Research and Global Distribution. Its competitors include Entero Healthcare and Take Solutions; 1 of its 2 listed competitors has raised funding.
Company details
Ytiliga Private Limited, founded in 2016 in Delhi, India, is a pharmaceutical company focused on research and innovation in healthcare. It produces high-quality drugs for specialties like gynaecology, urology, and nephrology, emphasizing agility and excellence. The company operates globally, offering affordable solutions through divisions such as UroTron and NephroTron, while prioritizing patient-centric approaches and intellectual property protection.
- Headquarters Delhi, India
- Employees 14
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website ytiliga.com
- Social LinkedIn
- Legal Name Ytiliga Private Limited
- Date of Incorporation 09 May, 2016
- Jurisdiction Delhi, India
- Annual Revenue₹1.14 Cr
FY 2024 · +30% YoY
- Net Profit₹2 Lakh
FY 2024 · 2% margin
- EBITDA₹3.9 Lakh
FY 2024 · 3% margin
- Employee Count14
Associated legal entities of Ytiliga
Ytiliga operates through Ytiliga Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ytiliga Private Limited CIN U74999DL2016PTC299316 | Active | 09 May 2016 | Delhi, Delhi | ₹1.1 Cr | 14 | 2 | View details |
Products & Services of Ytiliga
Ytiliga offers a comprehensive portfolio of products and services, including UroTron™, NephroTron™, AndroXprts™, and CNStron™.
Specialty drug for treating urological conditions effectively.
Medication for managing kidney-related disorders promptly.
Products focused on male reproductive health solutions.
Drugs for various targeted medical conditions worldwide.
Board of directors of Ytiliga Private Limited (Ytiliga)
Ytiliga Private Limited is the primary company behind Ytiliga. The board of Ytiliga Private Limited currently have 2 directors; the longest-serving is Praveen Kumar Singh, appointed in 2016.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Praveen Kumar Singh DIN 06537144 | Director | 09 May 2016 | 10 yrs 5 mo | Ytiliga Private Limited |
| Kamal Kishori Singh DIN 06547269 | Director | 09 May 2016 | 10 yrs 5 mo | Ytiliga Private Limited |
Financials of Ytiliga
Figures of Ytiliga Private Limited, the primary company behind Ytiliga, for FY 2024. Revenue was ₹1.14 Cr (+30% year on year). Net profit was ₹2 Lakh (2% margin). EBITDA was ₹3.9 Lakh (3% margin). Revenue has grown at a compounded annual rate of +44% over three years and +22% over five years.
- ₹1.14 CrRevenue · FY 2024 · +30% YoY
- ₹2 LakhNet profit · 2% margin
- ₹3.9 LakhEBITDA · 3% margin
- ₹10 LakhPaid-up capital
- 14Employees (provident fund records)
- +44%Revenue CAGR, 3 years
- +22%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ytiliga Private Limited are on its company page.
Detailed financial statements for Ytiliga
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Ytiliga
Ytiliga has 2 listed competitors in our database, 1 of them funded. They include Entero Healthcare and Take Solutions.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| takesolutions.com | 2000 | Chennai, India | 5 | Life sciences and supply chain management services are provided. |
Detailed competitors of Ytiliga
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ytiliga
The website of Ytiliga (ytiliga.com) receives about 680.7K visits a month.
- Monthly visits680.7K
▼ 6.7% vs previous month
Websites whose visitors overlap most with Ytiliga. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Ytiliga
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ytiliga
Ytiliga was founded in 2016.
Ytiliga is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Ytiliga has 14 employees.
The primary company behind Ytiliga, Ytiliga Private Limited, reported revenue of ₹1.14 Cr for FY 2024, up 30% year on year.
Ytiliga Private Limited, founded in 2016 in Delhi, India, is a pharmaceutical company focused on research and innovation in healthcare. It produces high-quality drugs for specialties like gynaecology, urology, and nephrology, emphasizing agility and excellence. The company operates globally, offering affordable solutions through divisions such as UroTron and NephroTron, while prioritizing patient-centric approaches and intellectual property protection.
Ytiliga's top competitors include Entero Healthcare and Take Solutions.
Ytiliga offers UroTronâ„¢, NephroTronâ„¢, AndroXprtsâ„¢, and CNStronâ„¢.
Ytiliga operates through Ytiliga Private Limited.
The legal entities of Ytiliga currently have 2 directors, including Praveen Kumar Singh, Kamal Kishori Singh.
The website of Ytiliga receives about 681 thousand visits a month.